問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberINS1009-311
Not yet recruiting

2025-12-31 - 2029-11-30

Phase III

Not yet recruiting6

ICD-10I27.2

Other secondary pulmonary hypertension

ICD-10I27.89

Other specified pulmonary heart diseases

ICD-9416.8

Other chronic pulmonary heart diseases

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Yu-Chao Lin Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 劉家榮 Division of General Internal Medicine

Co-Principal Investigator

  • 耿立達 Division of General Internal Medicine
  • 李志國 Division of General Internal Medicine
  • 張庭暐 Division of General Internal Medicine
  • 楊漢清 Division of General Internal Medicine
  • 柯政昌 Division of General Internal Medicine
  • 謝慕揚 Division of General Internal Medicine
  • 吳常瑋 Division of General Internal Medicine
  • 温岳峯 Division of General Internal Medicine
  • 張立禹 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chau-Chyun Sheu Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Jung-Yien Chien Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 吳懿哲 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 吳書豪 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chung-Yu Chen Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    18 participants

  • Global

    344 participants